Insider Trading & Ownership of Wellington Biomedical Innovation Master Investors (Cayman) II L.P.

Location
Boston, MA
Summary
The estimated net worth of Wellington Biomedical Innovation Master Investors (Cayman) II L.P. is at least $127,556,779 dollars as of 03 Feb 2025. Wellington Biomedical Innovation Master Investors (Cayman) II L.P. is the 10%+ Owner of RayzeBio, Inc. and owns shares of RayzeBio, Inc. stock worth about $97.37M. Wellington Biomedical Innovation Master Investors (Cayman) II L.P. is the 10%+ Owner of MBX Biosciences, Inc. and owns shares of MBX Biosciences, Inc. (MBX) stock worth about $19.14M. Wellington Biomedical Innovation Master Investors (Cayman) II L.P. is the 10%+ Owner of CARGO Therapeutics, Inc. and owns shares of CARGO Therapeutics, Inc. stock worth about $11.06M.
Signature
Wellington Biomedical Innovation Master Investors (Cayman) II L.P., By: Wellington Management Company LLP, as Investment Adviser, /s/ Peter N. McIsaac, Authorized Person
All Insider Reports
All Insider Reports

Notify me when Wellington Biomedical Innovation Master Investors (Cayman) II L.P. files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Wellington Biomedical Innovation Master Investors (Cayman) II L.P.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RYZB RayzeBio, Inc. 10%+ Owner $97,365,375 19 Sep 2023
MBX MBX Biosciences, Inc. 10%+ Owner $19,136,404 16 Sep 2024
CRGX CARGO Therapeutics, Inc. 10%+ Owner $11,055,000 14 Nov 2023
MTSR Metsera, Inc. 10%+ Owner 30 Jan 2025
UPB Upstream Bio, Inc. 10%+ Owner 15 Oct 2024

Insider Transactions Reported by Wellington Biomedical Innovation Master Investors (Cayman) II L.P.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.